Objective To identify patient characteristics and surgical factors predictive of complications requiring mid-urethral sling (MUS) revision/removal.
Introduction
Mid-urethral sling (MUS) procedures are the most commonly performed surgical treatment worldwide for female stress urinary incontinence because of their minimally invasive nature, short surgical time, and low complication rates. 1 Success rates for MUS are estimated to be 80-90% with excellent long-term durability; however, a small proportion of patients subsequently require reoperation for complications such as mesh erosion, mesh exposure, de novo urinary urgency and urge incontinence, recurrent urinary tract infections (UTIs), nerve injury, chronic pain, and most commonly voiding dysfunction/urinary retention. [2] [3] [4] [5] Database studies have found that 3-4% of women undergoing mesh procedures for stress urinary incontinence require mesh revision (or removal) within 10 years of the index surgery, 6, 7 and a recent systematic review of patients undergoing MUS implantation similarly found that 2.3% experience urinary retention requiring surgical revision.
Risk factors for MUS revision/removal are not well established partly because of its low incidence but also because much of the relevant literature has focused on short-term reoperation rates in small patient cohorts. 9, 10 Repeat surgery for MUS complications may often be delayed, however, rendering it likely that longer patient follow-up could yield different results. 10 Pre-existing voiding symptoms, retropubic sling type, concurrent surgery at the time of the index MUS procedure, and previous stress urinary incontinence (SUI) surgery have been suggested as potential risk factors for subsequent MUS revision, but have been based on data from small cohort studies. 9, 10 Large database studies have additionally suggested that apical resuspension and concurrent hysterectomy at the time of index surgery as well as younger patient age are risk factors for reoperation, but have been limited by their ability to adjust for potentially important patient and surgical confounding factors. 6, 7 Therefore, we sought to confirm previously reported factors, and to identify novel patient characteristics and surgical factors, predictive of complications requiring MUS revision using a case-control study design with longer-term follow-up and with sufficient power to adjust for potential confounding factors.
Methods

Case and control selection
A retrospective case-control study of patients undergoing MUS procedures at The Ottawa Hospital in Ottawa, Ontario, Canada, between 1 January 2005 and 31 December 2016, was performed. Follow-up was until 31 December 2017. The Ottawa Hospital is a tertiary care centre with three connected hospitals across the city of Ottawa serving a population of 1.2 million with six subspecialty-trained urogynaecologists who perform all MUS procedures. Consecutive patients were eligible for inclusion if they were female, were ≥18 years of age at the time of index MUS procedure, and had a current address in Ottawa or the surrounding area (in order to minimise losses during followup). All patients were confirmed as appropriate for inclusion via manual chart review. Core outcome measures and patient involvement were not relevant to the study.
Cases were included if they had undergone day surgery or inpatient surgery associated with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) code relating to mesh erosion, urinary retention, pain, urinary tract infection, wound complication, complication of prosthetic material, or mechanical complication of prosthetic device, implant or graft after the index MUS procedure. Patients without any medical or surgical inpatient or outpatient chart activity for more than 5 years after the index procedure were excluded, as there was concern that these patients may have relocated or that reoperation could have occurred at another centre. Controls were identified by screening patients who underwent MUS procedures immediately before and immediately after any given case patient to reduce the potential influence of specific surgeons or evolving surgical techniques. If the aforementioned inclusion criteria were not met or if a patient had already been used as a case or as a control, the next sequential patient was used until an appropriate control was identified. Patients who died of unrelated causes within 2 years of the index procedure were excluded to minimise the impact of competing risks.
Patient and surgical variables
Pre-specified patient and surgical data were collected using a standardised data collection form. Preoperative patient factors included age at the time of index MUS surgery, menopausal status, vaginal estrogen use, indication for MUS (SUI, latent SUI, prophylactic with prolapse repair, or unclear), post-void residual volume, maximal urethral closure pressure, previous failed incontinence procedure, previous hysterectomy, urgency symptoms, use of anticholinergic medication, smoking status, body mass index (BMI), diabetes mellitus, and a diagnosed pain disorder. Surgical factors included year of surgery, concomitant procedures performed, anaesthesia type, method of tensioning (cough or Valsalva manoeuvre versus instrument or visual), bladder perforation, and estimated blood loss. For cases, data on the type of MUS revision performed (complete mesh excision, pull-down of sling, or sling release), timing of reoperation, and indication for reoperation based on surgeon diagnosis (urinary retention, voiding dysfunction, pain, recurrent UTI, infection, or other) were also collected. As only a proportion of cases had formal urodynamic voiding studies prior to reoperation, the diagnosis of 'urinary retention' included cases of bladder outflow obstruction with incomplete bladder emptying. 'Voiding dysfunction' included cases of intermittent voiding patterns with normal post-void residual volumes.
Statistical analysis
We estimated that a sample size of 321 with a 2:1 case-tocontrol ratio (107 cases and 214 controls) would allow us to detect odds ratios of approximately 2.0 with 80% power, assuming a 25% prevalence of risk factors among controls. Categorical variables are reported as number (%) and were compared via v 2 or Fisher's exact tests. Continuous variables are reported as means AE standard deviations (SDs) or medians (interquartile ranges, IQRs), and were compared using Student's t-tests or Mann-Whitney U-tests, respectively. Crude and adjusted odds ratios (ORs) are reported with 95% confidence intervals (95% CIs). Unconditional simple and multivariable logistic regression models were fitted in order to maximise the use of the available data, as conditional models require excluding matched patients in cases of missing data on a predictor variable in a case or a control, resulting in a loss of relevant information. 11, 12 Three sets of pre-specified multivariable logistic regression models were fitted. Model 1 included previously reported risk factors for mesh revision after sling procedures for urinary incontinence: preoperative urge incontinence, preoperative use of anticholinergic medication, 9 type of sling (obturator versus retropubic), 9 concurrent surgery for pelvic organ prolapse (POP), 7,9,10 advanced age (≥60 years), moderate or greater degree of obesity (BMI ≥ 35 kg/m 2 ), and diabetes mellitus. 13 Model 2 included factors available to surgeons preoperatively only: advanced age, moderate or greater obesity, diabetes mellitus, pain disorder, smoking status, previous incontinence procedure, previous hysterectomy, urge incontinence, anticholinergic medication use, vaginal estrogen use, and postvoid residual volume of ≥150 ml. Model 3 included surgical factors, adjusted for potentially important preoperative characteristics: type of MUS performed (retropubic versus obturator), method of tensioning (cough versus instrument), concomitant procedure(s) performed (including single-or multi-compartment vaginal prolapse repair), anaesthesia used, estimated blood loss (<150 versus ≥150 ml), and predictor variables from model 2 with P ≤ 0.10. For all variables with missing data, an additional category of 'unknown' was included. These models were designed to examine previously reported risk factors for mesh revision after primary surgical treatment (model 1), to identify preoperative predictors of MUS complications requiring sling revision (model 2), and to identify surgical factors associated with this outcome after adjusting for significant preoperative factors (model 3), and ensuring that sufficient events were recorded per predictor variable. [14] [15] [16] No adjustment for multiplicity was performed. A retrospective sensitivity analysis using multiple imputation for missing data (Markov chain Monte Carlo method) instead of missing data indicators ('unknown' categories) was performed. All analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). A two-tailed a-level of 0.05 was used to define statistical significance.
Results
Patient and surgical characteristics
Of 4412 MUS procedures performed from 2005 to 2016, 107 patients (2.4%) required surgical revision and were included as cases. Indications for MUS revision included urinary retention (57%), voiding dysfunction (19%), exposed mesh (23%), pain (13%), erosion into urethra (0.9%), recurrent UTIs (12%), and other acute infections (0.9%). Twelve cases (11%) had multiple indications. The median time to revision was 153 days (IQR 49-432 days). Twenty-nine cases (27%) underwent MUS revision more than 1 year after the index procedure, 14 (13%) of whom required reoperation after more than 3 years. For MUS revision occurring more than 1 year after the index procedure, the indication was less likely to be for urinary retention (31 versus 69%, P < 0.01) and was more likely to be for multiple indications (24 versus 6%, P < 0.01). MUS revisions consisted of sling incision in 71 cases (66%), complete mesh excision in five cases (5%), partial mesh excision in 20 cases (19%), 'pull-down' of sling in three cases (3%), and 'other' in eight cases (7%). The latter group typically involved complete or partial mesh excision with a concurrent incontinence procedure.
Risk factors for MUS revision
Most preoperative patient characteristics were similar between cases and controls ( Table 1 ). In unadjusted analyses, active smoking status and previous hysterectomy were associated with complications requiring MUS revision, with ORs of 2.12 (95% CI 1.11-4.05) and 3.70 (95% CI 2.04-6.72), respectively (Table 1) , whereas no surgical factors were associated with this outcome (Table 2) .
Adjusted analyses of previously reported risk factors for MUS revision confirmed only concomitant surgery for POP and lack of preoperative urinary urgency as significant (Table 3) . Examining the independent predictive ability of preoperative factors for MUS revision identified current smoking status and having had a previous hysterectomy as positively associated with the outcome, whereas urinary urgency identified preoperatively exhibited a negative association (Table 4) . When including selected preoperative variables (those associated with P ≤ 0.10 in model 2) in a regression model of pre-specified potentially important surgical factors (model 3), current smoking status and having had a previous hysterectomy remained significant, as was concomitant surgery for POP (Table 5 ). Sensitivity analyses using multiple imputation for missing data yielded similar results (Tables S1-S3 ).
Discussion
Main findings
Current smoking status (OR 2.29, 95% CI 1.13-4.63, P = 0.02), previous hysterectomy (OR 3.88, 95% CI 2.02-7.46, P < 0.01), and concomitant surgery for pelvic organ prolapse (OR 2.63, 95% CI 1.32-5.25, P < 0.01) at the time of the index MUS procedure were associated with requiring surgical revision. Sling type (obturator versus retropubic), method of MUS tensioning (cough versus instrument), anaesthetic type, and estimated blood loss were not associated with this outcome in this analysis.
Strengths and limitations
Our analysis is the largest study of risk factors for MUS revision, affording greater statistical power and allowing for more robust adjustments for key patient characteristics than in previous efforts. 9, 10 Limitations of our study include the retrospective and single-centre case-control study design and the associated risk of selection bias.
Furthermore, there is a risk of misclassification. For instance, patients classified as controls may have undergone MUS revision at another centre and patients undergoing index MUS surgery at another centre were not captured. We believe this risk to be low, however, as The Ottawa Hospital is the only centre in Ottawa to provide specialised urogynaecology surgery, and measures to mitigate this risk were implemented at the time of the study design, including the requirement that all patients have active medical encounters at our centre for up to 5 years following the index MUS procedure, thereby selecting for patients who were likely to have been permanent city residents and who remained within the city during follow-up. Missing data for predictor variables could have influenced the magnitude and precision of effect estimates; however, missing data were included as additional categories in multivariable analyses to reduce their influence, and similar results were obtained in sensitivity analyses using multiple imputation.
Interpretation
Overall, 2.4% of patients undergoing MUS procedures at our centre between 2005 and 2016 subsequently required MUS revision-a figure that is comparable with cohort studies from subspecialty-trained, high-volume centres, 10 but lower than the previously reported rates of 3-4% when including a broader range of surgeons, including data from low-volume centres. 6, 7, 13 Indications for MUS revision among cases were also similar to those reported by other high-volume centres, with urinary retention being most common and roughly one in ten having multiple indications.
10,17 MUS revision was required at a median of 153 days after the index procedure, with 15% of re-operations occurring at >3 years. Similarly, long latency periods have been observed by others, highlighting the importance of long-term follow-up and/or facilitating re-referral in this patient population. 10, 17 Previous studies have identified a history of SUI surgery as a risk factor for MUS revision, 6,10 but this was not found to be significant in the present analysis. In contrast, active smoking status was independently associated with the need for mesh revision, and smoking has been noted as a risk factor for mesh exposure in both incontinence and prolapse repair procedures, 13, 18, 19 as well as being proposed as a risk factor for perioperative adverse events in general. 20 The mechanism for complications in smokers is generally believed to be related to impaired wound healing. 21 Similarly, the present study supports the association between concomitant prolapse surgery at the time of MUS, 22 particularly with apical suspension procedures, 10 although this has not been universally noted. 6 Some have postulated that anatomic changes related to POP repair may contribute to voiding dysfunction or urinary retention. Women undergoing prolapse repair with MUS or women who have had previous hysterectomy may also have pre-existing pelvic floor dysfunction that could contribute to dysfunctional voiding postoperatively. 23 Indeed, previous hysterectomy has seldom been considered in the literature, yet it was found to have a strong association with this outcome in our analysis. Finally, the length of the vaginal incision has been associated with mesh exposure, 13 which could be longer in women undergoing concomitant prolapse repairs.
Our analysis did not find an association between sling type and the need for subsequent MUS revision, which contradicts findings from smaller studies that have reported an increased risk of voiding dysfunction among women receiving retropubic slings, 22, 24 and an increased risk of mesh exposure with transobturator MUS. 25 Although the present study was powered for relatively large effects, it was not designed to identify predictors of MUS revision for specific indications, and a large proportion of the patients analysed had undergone retropubic sling implantation. Our centre has increasingly shifted to a preferential use of retropubic slings, given the reportedly higher success rates, 25, 26 lower rates of groin pain, 26 and ease of complete mesh removal if needed. 27 Similarly, no association was observed between the method of sling tensioning and the need for MUS revision.
Notably, this observation has been made in a previous casecontrol study, but without adjusting for potentially confounding variables. 9 At our centre, only six subspecialtytrained surgeons perform MUS procedures, with similar surgical volumes between them. Three surgeons preferentially tension by cough and three preferentially use instruments for tensioning. The low overall rate of MUS revision and the lack of association with method of tensioning suggest that either method of tensioning may be acceptable. Our study did not assess rates of recurrent incontinence among cases and controls, which may influence tensioning techniques. In addition, we were unable to adjust for a number of urodynamic parameters, which could also influence sling tensioning. 28 Preoperative urethral incompetence (as defined by a maximum urethral closure pressure, MUCP, of <20 cm H 2 O and/or an abdominal leak-point pressure of <60 cm H 2 O) was not included in our regression models because of the large number of patients with missing data for this variable, as a result of the high proportion of patients without urodynamic studies. The low rate of urodynamic testing may be linked to the fact that only 8% of patients had a history of SUI surgery and preoperative urodynamic testing does not improve surgical outcomes for primary SUI surgery. 29 One cohort study noted preexisting voiding dysfunction as a risk factor for MUS revision, 9 although only 59 patients were included in the analysis because of missing data. We hypothesised that preexisting urgency may be a proxy for voiding dysfunction, but found a negative association between preoperative urinary urgency and need for MUS revision after adjusting for other patient characteristics. Perhaps women with a component of detrusor overactivity are less likely to report postoperative voiding dysfunction given baseline symptoms; however, this remains speculative.
Conclusion
In our study, concomitant surgery for pelvic organ prolapse, current smoking status, and previous hysterectomy at the time of MUS surgery were positively and independently associated with the need for subsequent MUS revision.
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